echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Lingkang Pharmaceutical's Ceftizoxime Sodium for Injection Received "Drug Registration Approval"

    Lingkang Pharmaceutical's Ceftizoxime Sodium for Injection Received "Drug Registration Approval"

    • Last Update: 2021-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 1, Lingkang Pharmaceutical issued an announcement stating that its wholly-owned subsidiary, Meida Pharmaceutical, had received the Drug Registration Approval Document for Ceftizoxime Sodium for Injection approved and issued by NMPA.


    On June 14, 2012, Meida Pharm submitted its first domestic drug registration application to the State Food and Drug Administration for ceftizoxime sodium for injection and was accepted.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.